Literature DB >> 18657710

Relation between HIV viral load and infectiousness: a model-based analysis.

David P Wilson1, Matthew G Law, Andrew E Grulich, David A Cooper, John M Kaldor.   

Abstract

BACKGROUND: A consensus statement released on behalf of the Swiss Federal Commission for HIV/AIDS suggests that people receiving effective antiretroviral therapy-ie, those with undetectable plasma HIV RNA (<40 copies per mL)-are sexually non-infectious. We analysed the implications of this statement at a population level.
METHODS: We used a simple mathematical model to estimate the cumulative risk of HIV transmission from effectively treated HIV-infected patients (HIV RNA <10 copies per mL) over a prolonged period. We investigated the risk of unprotected sexual transmission per act and cumulatively over many exposures, within couples initially discordant for HIV status.
FINDINGS: Assuming that each couple had 100 sexual encounters per year, the cumulative probability of transmission to the serodiscordant partner each year is 0.0022 (uncertainty bounds 0.0008-0.0058) for female-to-male transmission, 0.0043 (0.0016-0.0115) for male-to-female transmission, and 0.043 (0.0159-0.1097) for male-to-male transmission. In a population of 10 000 serodiscordant partnerships, over 10 years the expected number of seroconversions would be 215 (80-564) for female-to-male transmission, 425 (159-1096) for male-to-female transmission, and 3524 (1477-6871) for male-to-male transmission, corresponding to an increase in incidence of four times compared with incidence under current rates of condom use.
INTERPRETATION: Our analyses suggest that the risk of HIV transmission in heterosexual partnerships in the presence of effective treatment is low but non-zero and that the transmission risk in male homosexual partnerships is high over repeated exposures. If the claim of non-infectiousness in effectively treated patients was widely accepted, and condom use subsequently declined, then there is the potential for substantial increases in HIV incidence. FUNDING: Australian Research Council.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18657710     DOI: 10.1016/S0140-6736(08)61115-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  125 in total

1.  Cervicovaginal shedding of HIV type 1 is related to genital tract inflammation independent of changes in vaginal microbiota.

Authors:  Caroline Mitchell; Jane Hitti; Kathleen Paul; Kathy Agnew; Susan E Cohn; Amneris E Luque; Robert Coombs
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-07       Impact factor: 2.205

2.  Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis.

Authors:  Deborah Donnell; Jared M Baeten; James Kiarie; Katherine K Thomas; Wendy Stevens; Craig R Cohen; James McIntyre; Jairam R Lingappa; Connie Celum
Journal:  Lancet       Date:  2010-05-26       Impact factor: 79.321

3.  Stressors and sources of support: the perceptions and experiences of newly diagnosed Latino youth living with HIV.

Authors:  Jaime Martinez; Diana Lemos; Sybil Hosek
Journal:  AIDS Patient Care STDS       Date:  2012-05       Impact factor: 5.078

Review 4.  Deadly public policy: what the future could hold for the HIV epidemic among injection drug users in Vancouver.

Authors:  Michael V O'Shaughnessy; Robert S Hogg; Steffanie A Strathdee; Julio S G Montaner
Journal:  Curr HIV/AIDS Rep       Date:  2012-12       Impact factor: 5.071

5.  Sexual risk taking among patients on antiretroviral therapy in an urban informal settlement in Kenya: a cross-sectional survey.

Authors:  Anders Ragnarsson; Anna Mia Ekström; Jane Carter; Festus Ilako; Abigail Lukhwaro; Gaetano Marrone; Anna Thorson
Journal:  J Int AIDS Soc       Date:  2011-04-18       Impact factor: 5.396

6.  Social Capital is Associated With Late HIV Diagnosis: An Ecological Analysis.

Authors:  Yusuf Ransome; Sandro Galea; Roman Pabayo; Ichiro Kawachi; Sarah Braunstein; Denis Nash
Journal:  J Acquir Immune Defic Syndr       Date:  2016-10-01       Impact factor: 3.731

7.  Integrated behavioral intervention to improve HIV/AIDS treatment adherence and reduce HIV transmission.

Authors:  Seth C Kalichman; Chauncey Cherry; Moira O Kalichman; Christina M Amaral; Denise White; Howard Pope; Connie Swetzes; Lisa Eaton; Rene Macy; Demetria Cain
Journal:  Am J Public Health       Date:  2011-01-13       Impact factor: 9.308

8.  Tracing of patients lost to follow-up and HIV transmission: mathematical modeling study based on 2 large ART programs in Malawi.

Authors:  Janne Estill; Hannock Tweya; Matthias Egger; Gilles Wandeler; Caryl Feldacker; Leigh F Johnson; Nello Blaser; Luisa Salazar Vizcaya; Sam Phiri; Olivia Keiser
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-15       Impact factor: 3.731

9.  Modeling the impact of Trichomonas vaginalis infection on HIV transmission in HIV-infected individuals in medical care.

Authors:  Evelyn Byrd Quinlivan; Shilpa N Patel; Catherine A Grodensky; Carol E Golin; Hsiao-Chuan Tien; Marcia M Hobbs
Journal:  Sex Transm Dis       Date:  2012-09       Impact factor: 2.830

10.  My partner wants a child: a cross-sectional study of the determinants of the desire for children among mutually disclosed sero-discordant couples receiving care in Uganda.

Authors:  Jolly Beyeza-Kashesya; Anna Mia Ekstrom; Frank Kaharuza; Florence Mirembe; Stella Neema; Asli Kulane
Journal:  BMC Public Health       Date:  2010-05-13       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.